Fungizone (amphotericin B) Oral Suspension

    Bristol-Myers Squibb is finally marketing Fungizone (amphotericin B) Oral Suspension...for treating oral candidiasis.

    This suspension was approved over 25 years ago. But it's just now being marketed because of the increasing incidence of oral candidiasis...particularly in patients with HIV or cancer.

    Patients use the oral suspension QID...swish and swallow.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote